The Next RCM Advantage Starts Before the Claim
The revenue problem may begin long before billing
A client calls because denials are rising. Your revenue cycle team reviews the claims, checks the codes, studies payer patterns, and confirms that billing followed the established process. Yet the same problem keeps returning.
The cause may sit somewhere else. A provider enrollment record may be wrong. The clinical note may not support medical necessity. A prior authorization workflow may rely on an outdated payer rule. Quality-reporting data may not match the organization’s provider list. A CMS requirement may have changed, but no one translated it into daily operations.
The claim is where the financial problem becomes visible. It is not always where the problem begins.
That distinction creates a timely opportunity for revenue cycle management companies. RCM companies do not need to become regulatory consulting firms. They do, however, need a reliable way to help clients when reimbursement, reporting, documentation, technology, and healthcare regulation collide.
RCM companies already receive regulatory-performance questions
Practices rarely sort a problem into the correct professional category before asking for help. They call the partner closest to the financial result. In many organizations, that partner is the RCM company.
Your account managers may already hear questions such as:
Will this CMS rule change our reimbursement?
Why does this denial keep returning after we corrected the claim?
Does our documentation support the service we billed?
Could this issue affect our MIPS score?
Does our EHR capture the evidence required for Promoting Interoperability?
Who owns the correction when credentialing and billing records disagree?
What does our ACO participation require from this practice?
Is this a coding problem, a workflow problem, or a compliance problem?
These questions may arrive through denial reviews, client meetings, coding audits, payer updates, and performance reports. They sit close to revenue cycle operations, but many require expertise outside traditional billing and coding compliance.
When the RCM team lacks a defined route for these questions, staff may improvise, redirect the client, or leave the issue unresolved. None of those choices strengthens the relationship.
Pause and ask: Where do regulatory-performance questions go inside your company today? If the answer depends on who happens to be available, you have found a capability gap.
Billing compliance and regulatory performance solve different problems
Claims and coding compliance asks whether the organization billed the correct service, used the proper code, met payer requirements, and can support the claim.
Revenue integrity looks across the payment process to identify missed charges, underpayments, coding variation, documentation weaknesses, and other causes of lost or inaccurate revenue.
Regulatory performance asks a broader question: Can the organization prove that it met the requirements of a government program, quality framework, interoperability measure, value-based contract, or audit?
The capabilities overlap, but they are not interchangeable. A correct claim does not prove that a practice collected the right quality data, maintained its Promoting Interoperability evidence, aligned its ACO provider roster, or translated a new CMS policy into operations.
Billing compliance asks, Can we defend this claim?
Regulatory performance asks, Can we prove that the organization met the program requirement?
A regulatory partner does not replace the RCM company’s billing expertise. It interprets the rules, evidence, and operational dependencies surrounding the revenue cycle.
The 2026 and 2027 policy environment raises the stakes
The case for partnership rests on specific operational changes that require sustained preparation.
For 2026 MIPS, eligible clinicians participating in Promoting Interoperability must use a continuous 180-day performance period. Practices need working certified technology, reliable measure capture, security documentation, public-health reporting evidence, and clear ownership throughout that period. CMS Quality Payment Program timeline
ACO requirements connect quality, technology, provider data, and financial performance. In 2024, Shared Savings Program ACOs earned $4.1 billion in shared savings and saved Medicare $2.5 billion. Those outcomes depend on far more than clean claims. CMS 2026 ACO participation highlights
At the same time, electronic prior authorization is moving from policy discussion into implementation. Under the CMS Interoperability and Prior Authorization Final Rule, impacted payers must implement several API requirements by January 1, 2027. That shift will affect data exchange, documentation, workflow design, payer communication, and the way practices understand authorization status and decisions. CMS Interoperability and Prior Authorization Final Rule
Clients need more than alerts. They need to know who owns the response, what evidence to retain, and how each requirement affects revenue operations.
More financial risk is forming upstream of the claim
Denial dashboards remain valuable. They show payer trends, denial reasons, rework, accounts receivable, and financial impact. But they often begin late in the story.
An upstream review may uncover:
Provider enrollment data that conflicts with credentialing or billing records
Authorization rules that staff have not translated into specialty workflows
Documentation templates that fail to support medical necessity
Quality measures that depend on data stored only in narrative notes
Promoting Interoperability evidence that no one retains in an audit-ready file
ACO participant lists that do not match operational systems
New regulatory requirements that never reached the people doing the work
Unclear ownership across compliance, clinical, health IT, credentialing, and billing teams
Each one can delay payment, increase rework, weaken reporting, frustrate clients, or expose the organization during an audit. A useful RCM strategy examines both what happened to the claim and what happened before it existed.
A regulatory partnership protects the client relationship
When an RCM company cannot address a client’s regulatory-performance problem, the client will look elsewhere. The new adviser may be a compliance consultant, EHR specialist, quality-reporting vendor, ACO consultant, or competing RCM organization with broader services.
The immediate risk is not always account loss. It is loss of influence. The outside adviser gains access to the client’s executives, workflows, data concerns, and strategic plans while the RCM company remains responsible for the financial result.
A regulatory partnership lets the RCM company keep the relationship connected. The RCM team can recognize the issue, bring in specialized support, and remain involved in the solution. The client receives a coordinated response instead of another referral into the healthcare wilderness.
This approach can strengthen retention, improve account-manager confidence, speed escalation, clarify responsibilities, and create new advisory services. The goal is not to claim expertise your team does not have. It is to give clients access to that expertise through a relationship they already trust.
Partnership can test demand without building a new department
An RCM company has three basic choices when regulatory-performance needs increase:
Decline or redirect the work.
Build the capability internally.
Partner with a specialized regulatory organization.
Building internally may suit some large companies. It also requires specialized recruitment, policy monitoring, service design, training, quality controls, and enough demand to support the cost.
A partnership provides a practical middle path. It allows an RCM company to test client demand and operational fit before adding permanent overhead.
Potential services may include:
Regulatory revenue risk assessments
CMS policy impact briefings
MIPS and Promoting Interoperability readiness reviews
Documentation and workflow assessments
Audit-evidence validation
ACO and value-based care readiness support
Specialty-specific compliance guidance
Training for account managers and operations teams
White-label or co-branded client education
No company needs to launch every service at once. Please do not unveil a twelve-service compliance division by next Tuesday. Start with one recurring client problem and test a focused solution.
Start with a controlled regulatory partnership pilot
A useful pilot should be narrow enough to manage and meaningful enough to measure. We recommend defining:
One client segment: Select a specialty, practice type, or value-based care group.
One problem: Focus on a repeated issue involving documentation, MIPS, Promoting Interoperability, audit evidence, provider data, or another clear risk.
Three to five client reviews: Use a small group to identify common patterns without disrupting the full client base.
One account-team briefing: Teach client-facing staff how to recognize the issue and escalate it correctly.
A clear scope: Define what the RCM company owns, what the regulatory partner owns, and what remains the client’s responsibility.
Success measures: Track client interest, risks identified, corrective actions, staff usefulness, expansion opportunities, and delivery effort.
A decision point: At the end, decide whether to stop, refine, or expand the service.
Before selecting a partner, ask how it will protect your client relationship. A credible regulatory partner should translate policy into usable action, understand the limits of its role, produce concise findings, avoid promises of guaranteed compliance or reimbursement, and support your established account-management process.
The right partner should make your team more valuable to the client, not make the client wonder who is in charge.
The next question belongs inside your company
Revenue cycle management will always require strong billing, coding, follow-up, and payment operations. Those capabilities remain essential. But more client revenue problems now cross into quality reporting, interoperability, provider data, documentation, value-based care, and regulatory evidence.
The next RCM advantage may come from recognizing those issues before the claim exposes them.
At Chirpy Bird, we believe RCM companies should not have to choose between turning away regulatory-performance questions and building an entirely new department. A well-designed partnership can extend client value while keeping scope, responsibility, and client ownership clear.
Ask your team one question: When a client’s revenue problem is regulatory, operational, or evidence-based, where does it go?
If the answer is unclear, it may be time to test a better route.
